- Excellent financial health (Piotroski 7/9)
- High gross margin of 85.5%
- Strong return on equity of 81.3%
Zevra Therapeutics, Inc. stock price up 2.19% on Friday
(Updated on Jun 26, 2026)
The Zevra Therapeutics, Inc. stock price gained 2.19% on the last trading day (Friday, 26th Jun 2026), rising from $13.23 to $13.52. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.15% from a day low at $13.20 to a day high of $13.88. The price has risen in 6 of the last 10 days and is up by 4.24% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $38.91 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.06% during the next 3 months and, with a 90% probability hold a price between $15.42 and $19.43 at the end of this 3-month period.
ZVRA Signals & Forecast
The Zevra Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.00 and $11.70. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -1.02%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Zevra Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $12.65 and $12.09. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zevra Therapeutics, Inc. finds support just below today's level at $12.65. If this is broken, then the next support from accumulated volume will be at $12.09 and $11.40.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.680 between high and low, or 5.15%. For the last week, the stock has had daily average volatility of 4.33%.
Our recommended stop-loss: $13.02 (-3.66%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)
Trading Expectations (ZVRA) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Zevra Therapeutics, Inc. to open at $13.53, and during the day (based on 14 day Average True Range), to move between $13.19 and $13.85, which gives a possible trading interval of +/-$0.662 (+/-5.02%) up or down from last closing price. If Zevra Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.02% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $13.66 (1.04%) than the support at $12.65 (6.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Zevra Therapeutics, Inc. stock A Buy?
Zevra Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score:
5.292
Strong Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 29, 2026 - $13.53 ( 0.0986%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ZVRA Performance
Trading levels for ZVRA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.21 | 5.13% |
| R2 | 13.95 | 3.21% |
| R1 | 13.79 | 2.02% |
| Price | 13.52 | |
| S1 | 13.27 | -1.82% |
| S2 | 13.11 | -3.01% |
| S3 | 12.85 | -4.93% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 13.66 | 1.04% |
| Price | 13.52 | |
| S1 | 12.65 | -6.43% |
| S2 | 12.09 | -10.58% |
| S3 | 11.40 | -15.68% |
FAQ
Click here for our free guide on how to buy Zevra Therapeutics, Inc. Stock.
Buy ZVRA